Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Fill told Drugwatch
Pituitary Interaction Studies CJC-1295 (Mod GRF 1-29) appears to engage with growth hormone-releasing hormone (GHRH) receptors located in pituitary somatotroph cells
They become especially important when there are drug shortages or when patients require formulations without certain allergens or in specific doses that arent commercially available
The higher-strength injection is approved for use in conjunction with increased physical activity and a reduced-calorie diet for patients who have tolerated the 2.4 mg dose for at least four weeks but still need additional weight loss
US$ 26.49
US$ 20.63
US$ 29.53
